Jointown Pharmaceutical Group Co Ltd
SSE:600998
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
CN |
|
Wingtech Technology Co Ltd
SSE:600745
|
CN |
Balance Sheet
Balance Sheet Decomposition
Jointown Pharmaceutical Group Co Ltd
Jointown Pharmaceutical Group Co Ltd
Balance Sheet
Jointown Pharmaceutical Group Co Ltd
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
1 132
|
1 378
|
1 578
|
1 188
|
2 148
|
2 400
|
3 202
|
3 588
|
6 109
|
5 236
|
8 541
|
12 699
|
12 171
|
14 809
|
7 077
|
7 660
|
8 809
|
7 800
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
40
|
40
|
22
|
25
|
18
|
16
|
17
|
14
|
9
|
7 077
|
7 660
|
8 809
|
7 800
|
|
| Cash Equivalents |
1 132
|
1 378
|
1 578
|
1 188
|
2 148
|
2 360
|
3 162
|
3 566
|
6 084
|
5 218
|
8 525
|
12 682
|
12 157
|
14 800
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
8
|
4
|
0
|
0
|
7
|
0
|
1
|
0
|
43
|
3 886
|
410
|
185
|
987
|
|
| Total Receivables |
582
|
612
|
774
|
1 470
|
2 506
|
3 860
|
5 193
|
8 141
|
10 878
|
14 548
|
20 160
|
26 653
|
29 219
|
32 688
|
32 897
|
34 905
|
34 231
|
37 556
|
|
| Accounts Receivables |
249
|
220
|
360
|
556
|
927
|
1 680
|
2 753
|
5 100
|
7 798
|
9 076
|
14 106
|
20 715
|
22 913
|
25 077
|
26 406
|
27 576
|
24 720
|
29 477
|
|
| Other Receivables |
333
|
392
|
414
|
914
|
1 579
|
2 180
|
2 440
|
3 041
|
3 080
|
5 472
|
6 054
|
5 938
|
6 306
|
7 611
|
6 491
|
7 329
|
9 511
|
8 079
|
|
| Inventory |
1 561
|
2 080
|
2 631
|
3 143
|
3 817
|
4 137
|
4 934
|
6 311
|
8 114
|
10 152
|
12 182
|
13 891
|
14 072
|
14 775
|
15 517
|
17 213
|
20 114
|
22 851
|
|
| Other Current Assets |
399
|
570
|
812
|
697
|
1 296
|
1 489
|
1 815
|
1 835
|
2 121
|
2 220
|
2 589
|
3 811
|
3 441
|
3 834
|
11 792
|
15 470
|
12 286
|
15 030
|
|
| Total Current Assets |
3 674
|
4 640
|
5 795
|
6 498
|
9 767
|
11 894
|
15 148
|
19 874
|
27 221
|
32 164
|
43 473
|
57 057
|
58 903
|
66 150
|
71 170
|
75 658
|
75 625
|
84 225
|
|
| PP&E Net |
548
|
755
|
959
|
1 189
|
1 544
|
1 881
|
2 333
|
2 976
|
3 543
|
4 403
|
5 291
|
6 028
|
6 505
|
7 413
|
8 521
|
8 648
|
8 963
|
8 978
|
|
| PP&E Gross |
0
|
0
|
959
|
1 189
|
1 544
|
1 881
|
2 333
|
2 976
|
3 543
|
4 403
|
5 291
|
6 028
|
6 505
|
7 413
|
8 521
|
8 648
|
8 963
|
8 978
|
|
| Accumulated Depreciation |
0
|
0
|
193
|
264
|
340
|
437
|
545
|
703
|
898
|
1 086
|
1 333
|
1 643
|
1 973
|
2 309
|
2 700
|
3 101
|
3 549
|
3 869
|
|
| Intangible Assets |
167
|
252
|
331
|
359
|
379
|
589
|
631
|
739
|
884
|
1 028
|
1 165
|
1 291
|
2 232
|
2 271
|
2 272
|
2 003
|
2 048
|
2 201
|
|
| Goodwill |
0
|
0
|
2
|
0
|
17
|
58
|
58
|
74
|
82
|
87
|
145
|
126
|
343
|
554
|
581
|
813
|
760
|
799
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
4
|
2
|
1
|
2
|
37
|
15
|
8
|
8
|
|
| Long-Term Investments |
29
|
68
|
73
|
97
|
107
|
335
|
389
|
404
|
764
|
889
|
1 763
|
1 912
|
2 849
|
4 066
|
2 946
|
4 619
|
4 777
|
5 390
|
|
| Other Long-Term Assets |
7
|
4
|
8
|
17
|
25
|
47
|
36
|
57
|
90
|
148
|
206
|
258
|
315
|
367
|
408
|
556
|
607
|
0
|
|
| Other Assets |
0
|
0
|
2
|
0
|
17
|
58
|
58
|
74
|
82
|
87
|
145
|
126
|
343
|
554
|
581
|
813
|
760
|
799
|
|
| Total Assets |
4 424
N/A
|
5 719
+29%
|
7 168
+25%
|
8 160
+14%
|
11 839
+45%
|
14 804
+25%
|
18 596
+26%
|
24 125
+30%
|
32 585
+35%
|
38 729
+19%
|
52 048
+34%
|
66 674
+28%
|
71 148
+7%
|
80 824
+14%
|
85 936
+6%
|
92 312
+7%
|
92 789
+1%
|
102 396
+10%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
940
|
949
|
966
|
993
|
1 808
|
2 226
|
3 236
|
4 626
|
6 278
|
7 467
|
9 996
|
10 693
|
12 279
|
13 138
|
12 802
|
39 295
|
40 101
|
46 510
|
|
| Accrued Liabilities |
20
|
38
|
25
|
17
|
15
|
46
|
63
|
80
|
93
|
104
|
181
|
285
|
374
|
446
|
792
|
1 070
|
991
|
1 006
|
|
| Short-Term Debt |
1 818
|
2 802
|
3 647
|
2 277
|
3 927
|
4 659
|
6 929
|
7 851
|
13 566
|
14 592
|
17 226
|
28 768
|
28 376
|
32 286
|
34 396
|
11 471
|
10 109
|
9 917
|
|
| Current Portion of Long-Term Debt |
17
|
0
|
130
|
115
|
1 104
|
957
|
863
|
1 145
|
0
|
1 600
|
0
|
7
|
97
|
64
|
1 835
|
493
|
2 118
|
1 560
|
|
| Other Current Liabilities |
265
|
184
|
228
|
281
|
296
|
392
|
482
|
663
|
1 074
|
1 496
|
3 299
|
4 513
|
4 821
|
5 398
|
5 569
|
7 355
|
6 747
|
7 410
|
|
| Total Current Liabilities |
3 061
|
3 973
|
4 996
|
3 683
|
7 150
|
8 280
|
11 573
|
14 365
|
21 010
|
25 259
|
30 702
|
44 266
|
45 948
|
51 332
|
55 394
|
59 684
|
60 066
|
66 403
|
|
| Long-Term Debt |
80
|
265
|
489
|
429
|
354
|
1 636
|
1 610
|
1 596
|
1 600
|
1 289
|
1 462
|
1 626
|
2 724
|
3 205
|
2 559
|
3 176
|
2 507
|
1 717
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
20
|
32
|
23
|
26
|
21
|
15
|
16
|
120
|
352
|
566
|
460
|
378
|
347
|
|
| Minority Interest |
25
|
36
|
41
|
121
|
193
|
249
|
240
|
287
|
491
|
732
|
1 237
|
1 915
|
3 213
|
3 790
|
3 664
|
4 046
|
5 494
|
6 350
|
|
| Other Liabilities |
2
|
3
|
10
|
26
|
31
|
32
|
41
|
53
|
104
|
149
|
332
|
384
|
388
|
317
|
343
|
306
|
361
|
336
|
|
| Total Liabilities |
3 168
N/A
|
4 278
+35%
|
5 537
+29%
|
4 259
-23%
|
7 728
+81%
|
10 217
+32%
|
13 497
+32%
|
16 324
+21%
|
23 230
+42%
|
27 451
+18%
|
33 748
+23%
|
48 207
+43%
|
52 394
+9%
|
58 997
+13%
|
62 527
+6%
|
67 672
+8%
|
68 806
+2%
|
75 153
+9%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
783
|
1 171
|
1 271
|
1 421
|
1 421
|
1 421
|
1 421
|
1 643
|
1 647
|
1 647
|
1 879
|
1 878
|
1 878
|
3 857
|
3 856
|
3 856
|
3 909
|
6 814
|
|
| Retained Earnings |
453
|
255
|
342
|
709
|
927
|
1 340
|
1 818
|
2 217
|
2 912
|
3 518
|
4 856
|
5 789
|
7 181
|
10 155
|
11 546
|
12 950
|
14 054
|
15 585
|
|
| Additional Paid In Capital |
19
|
16
|
19
|
1 772
|
1 763
|
1 826
|
1 765
|
3 884
|
3 988
|
3 978
|
7 909
|
7 996
|
8 131
|
8 095
|
8 056
|
8 205
|
6 353
|
5 207
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
214
|
258
|
279
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
254
|
143
|
497
|
340
|
805
|
858
|
615
|
774
|
582
|
632
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
96
|
57
|
1 062
|
2 278
|
4 154
|
3 144
|
2 370
|
579
|
565
|
189
|
10
|
10
|
|
| Total Equity |
1 255
N/A
|
1 441
+15%
|
1 631
+13%
|
3 901
+139%
|
4 111
+5%
|
4 587
+12%
|
5 100
+11%
|
7 801
+53%
|
9 355
+20%
|
11 278
+21%
|
18 300
+62%
|
18 467
+1%
|
18 754
+2%
|
21 827
+16%
|
23 409
+7%
|
24 640
+5%
|
23 983
-3%
|
27 243
+14%
|
|
| Total Liabilities & Equity |
4 424
N/A
|
5 719
+29%
|
7 168
+25%
|
8 160
+14%
|
11 839
+45%
|
14 804
+25%
|
18 596
+26%
|
24 125
+30%
|
32 585
+35%
|
38 729
+19%
|
52 048
+34%
|
66 674
+28%
|
71 148
+7%
|
80 824
+14%
|
85 936
+6%
|
92 312
+7%
|
92 789
+1%
|
102 396
+10%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
783
|
1 171
|
1 271
|
1 421
|
1 421
|
1 421
|
1 421
|
1 643
|
1 647
|
1 647
|
1 879
|
1 878
|
1 878
|
1 874
|
5 042
|
5 042
|
5 042
|
5 042
|
|